市場調査レポート
商品コード
1466121

臨床検査薬市場:検査タイプ、適応症、エンドユーザー別-2024-2030年の世界予測

Clinical Laboratory Tests Market by Test Type (Basic Metabolic Panel, Complete Blood Count, Comprehensive Metabolic Panel), Indication (Autoimmune Diseases, Cardiovascular Diseases, Genetic Disorders), End-User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
臨床検査薬市場:検査タイプ、適応症、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床検査薬市場規模は2023年に1,357億2,000万米ドルと推計され、2024年には1,453億1,000万米ドルに達し、CAGR 7.27%で2030年には2,218億6,000万米ドルに達すると予測されます。

臨床検査薬市場には、病気、状態、感染を検出するための診断ラボによる様々な検査やサービスの販売と提供が含まれます。これらのサービスには、血液、尿、組織検体に対する生化学的、遺伝学的、微生物学的、病理学的、分子生物学的検査が含まれます。同市場は、予防医療や個別化医療を重視する病院、診療所、単独検査室、学術機関など、幅広いエンドユーザーにサービスを提供しています。臨床検査薬の用途は幅広く、日常的なスクリーニングや診断から高度な予後予測や治療モニタリングまで多岐にわたる。エンドユーザーは通常、病院やクリニックなどのヘルスケアプロバイダーであり、これらの検査は患者ケアのために必要です。さらに、法医学機関や研究機関では、科学的分析や研究目的でこれらの検査を利用しています。臨床検査薬市場は、高齢化、慢性疾患の蔓延、世界のヘルスケア支出の増加、個別化医療への嗜好の高まりなど、いくつかの成長要因の影響を受けています。しかし、臨床検査薬に関連するコストの高さや、臨床検査薬に関する規制の枠組みの厳しさなどの課題に直面しています。一方、診断精度を高めるための人工知能と機械学習の統合、非侵襲的検査法の採用、ポイントオブケア診断の開発などを通じて、市場は潜在的なビジネスチャンスをもたらしています。ヘルスケアインフラが発展している新興国市場への開拓、研究開発のための戦略的提携は、潜在的成長の有望分野です。

主な市場の統計
基準年[2023] 1,357億2,000万米ドル
予測年[2024] 1,453億1,000万米ドル
予測年 [2030] 2,218億6,000万米ドル
CAGR(%) 7.27%

検査の種類より包括的な視野で基礎代謝情報を提供する総合代謝パネルの利用が拡大

基礎代謝パネルは、グルコース、カルシウム、電解質などの血液中の特定物質の濃度を算出し、身体の代謝に関する重要な情報を提供します。カルシウムは骨の健康、筋肉の収縮、神経機能、血液凝固に不可欠です。BMPは血液中の総カルシウム濃度を測定し、骨疾患、副甲状腺疾患、悪性腫瘍の発見に重要です。ナトリウム、カリウム、塩化物、重炭酸塩などの電解質は、体液バランス、心臓のリズム、筋肉機能、その他の生理的プロセスの維持に重要です。BMPはこれらの電解質のバランスを評価するもので、腎機能、水分摂取量、投薬、慢性疾患など様々な要因によって影響を受けます。BMPの中のグルコース検査は、糖尿病の診断とグルコースコントロールのモニタリングのための基本的なツールであり、それによって効果的な糖尿病管理と合併症の予防に貢献します。BMPに含まれる腎臓の検査には、通常、血中尿素窒素(BUN)とクレアチニンの測定が含まれ、これらは腎臓の機能と血液中の老廃物の除去効率を示します。全血球算定は広く行われている血液検査で、全身の健康状態を評価し、貧血や感染症などのさまざまな疾患をスクリーニングします。赤血球、ヘモグロビン、白血球、ヘマトクリット、血小板など、血液のさまざまな部分を測定します。包括的メタボリックパネルには、BMPのすべての血液検査が含まれ、さらに肝機能とタンパク質レベルに関するマーカーが追加されます。総合代謝パネル(CMP)の肝臓検査項目には、肝機能を評価するいくつかの重要な測定項目が含まれています。アラニンアミノトランスフェラーゼ(ALT)やアスパラギン酸アミノトランスフェラーゼ(AST)などの主要な肝酵素は、肝障害や肝細胞疾患を検出するために分析されます。CMPにおけるタンパク質値は、血液中の2つの主要なタンパク質であるアルブミンと総タンパク質に焦点を当てています。アルブミン値を測定することで、肝臓の合成機能を確認し、栄養不足や腎臓病を特定することができます。脂質プロファイルは、血液中の特定の脂質の量を測定することによって心臓のリスクを評価するために使用される一連の検査です。これには通常、コレステロールのサブタイプであるLDL(低比重リポ蛋白)、HDL(高比重リポ蛋白)、トリグリセライドが含まれます。甲状腺検査では、甲状腺機能を評価し、甲状腺疾患を診断するために、甲状腺刺激ホルモン(TSH)、T3、T4を測定することがよくあります。これらの検査は、甲状腺機能低下症や甲状腺機能亢進症などの状態を管理するために極めて重要です。尿検査は尿を調べる検査で、尿路感染症、腎臓病、糖尿病など、さまざまな疾患を検出することができます。尿検査には、尿の物理的、化学的、顕微鏡的な側面を含むいくつかの検査が含まれます。

適応:予測分析と精密医療の重要性の高まりに伴う遺伝子疾患検査の進歩

自己免疫疾患は、免疫系が誤って自分自身の細胞を攻撃することで発症します。これらの疾患に対する臨床検査薬は、自己抗体の検出と臓器機能の評価を目的としています。リウマトイド因子(RF)、抗核抗体(ANA)、環状シトルリン化ペプチド(CCP)などの検査が広く行われています。心血管疾患では、脂質プロファイル、心臓バイオマーカー、凝固パネル、炎症マーカーなどの検査が必要です。これらの検査はリスク評価、診断、疾病管理に役立ちます。遺伝性疾患については、核型分析、DNAシークエンシング、マイクロアレイ分析などの分子・細胞遺伝学的検査に重点が置かれています。これらの検査は、ダウン症候群、嚢胞性線維症、ハンチントン病などの診断に用いられます。感染症検査は病原体の同定を目的としたもので、細菌培養、PCR検査、血清学的検査、感受性検査などが含まれます。これらの検査は、感染症の適時適切な治療に不可欠です。腫瘍学的診断学は、腫瘍マーカー、ゲノム検査、リキッドバイオプシーを含む幅広い検査を含んでいます。これらの検査は、がん患者の早期発見、病期分類、治療方針の決定、モニタリングに役立ちます。

エンドユーザー:広範な検査範囲と費用対効果により、独立した検査室への選好が高まる

病院ベースの検査室は、患者の診断と治療に必要な幅広い臨床検査を提供する病院内の施設です。病院内検査室の必要性は、入院患者のケアに便利であることと、患者管理における緊急の意思決定のために迅速な結果を提供できることに起因します。病院の検査室は、日常的な血液検査、重症患者に対する特殊検査、緊急診断に不可欠です。独立した検査室は、病院に併設されることなく臨床検査サービスを提供する独立した施設です。外来患者施設と個人の両方にサービスを提供し、小規模の病院検査室では費用対効果が低いような専門的で大量の検査を提供することが多いです。独立した検査室が好まれるのは、コストが安いこと、より包括的な検査メニューがあること、希少な疾患や複雑な疾患の診断サービスがあることが多いです。

地域別の洞察

米国では、高度なヘルスケア・インフラ、高額な医療費、研究開発の重視が市場を牽引しています。消費者のニーズは個別化と利便性に集中しており、家庭用検査キットが人気を集めています。カナダの消費者は予防医療への関心を高めており、より包括的な健康スクリーニング検査を求めています。カナダ政府は、患者の転帰を改善するため、ラボ検査を含むヘルスケアへの投資を日常的に行っています。欧州連合(EU)の臨床検査薬市場は、高品質の基準を保証する厳しい政策と指令によって規制されています。人口の高齢化に伴い、慢性疾患をモニターするためのラボ検査の需要が高まっています。EUにおける最先端の研究や注目すべき特許は、検査効率の改善やラボプロセスの環境負荷低減に関連することが多いです。中東・アフリカ地域では、国民の健康意識が急上昇しています。このような健康意識の高まりは、定期的な臨床検査薬を含む予防ヘルスケアサービスに対する需要の高まりにもつながっています。健康状態の早期診断やモニタリングに対する人々の関心の高まりは、同地域の臨床検査薬市場の業績を牽引する重要な要因となっています。APACでは、中国がヘルスケアインフラを急速に拡大し、政府の医療改革への投資拡大により臨床検査サービスへの需要が高まっています。インドの臨床検査薬市場は、ヘルスケア意識の高まりと非感染性疾患の有病率の増加により急成長しています。民営化と健康保険の拡大により、臨床検査はより身近なものとなった。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、臨床検査薬市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、臨床検査薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.臨床検査薬市場の市場規模および予測は?

2.臨床検査薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.臨床検査薬市場の技術動向と規制枠組みは?

4.臨床検査薬市場における主要ベンダーの市場シェアは?

5.臨床検査薬市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の増加
      • 世界中でヘルスケア費が増加
      • 個別化医療への関心の高まり
    • 抑制要因
      • 臨床検査薬に関連する高コスト
    • 機会
      • ポイントオブケア検査の必要性の高まり
      • デジタルソリューションと臨床検査の統合
    • 課題
      • 臨床検査に関する厳格な規制枠組み
  • 市場セグメンテーション分析
    • 検査の種類:基礎的な代謝情報をより包括的な視点で提供するため、包括的な代謝パネルの利用が拡大しています。
    • 適応症:予測分析と精密医療の重要性の高まりによる遺伝性疾患検査の進歩
    • エンドユーザー:より広範なリーチとコスト効率の良さから、独立系ラボが好まれる傾向が高まっている
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 臨床検査薬市場テストタイプ別

  • 基礎代謝パネル
  • 完全血球計算
  • 包括的代謝パネル
  • 脂質プロファイル
  • 甲状腺検査
  • 尿検査

第7章 臨床検査薬市場適応症別

  • 自己免疫疾患
  • 心血管疾患
  • 遺伝性疾患
  • 感染症
  • 腫瘍性疾患

第8章 臨床検査薬市場:エンドユーザー別

  • 病院ベースの検査室
  • 独立研究所

第9章 南北アメリカの臨床検査薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の臨床検査薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの臨床検査薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • オンクエスト・ラボラトリーズ社はシュルティ・クリニカル・ラボラトリー社と提携し、商業の中心地ムンバイでのプレゼンスを強化
    • レッドクリフ・ラボがメディセンター・ソノグラフィー&クリニカル・ラボを買収
    • クエスト・ダイアグノスティクス、メイン州のノーザン・ライト・ラボラトリーの買収を完了
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CLINICAL LABORATORY TESTS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL LABORATORY TESTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL LABORATORY TESTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CLINICAL LABORATORY TESTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL LABORATORY TESTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CALCIUM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CALCIUM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GLUCOSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PROTEINS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY THYROID TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY THYROID TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY URINALYSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ONCOLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ONCOLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2023 (US
目次
Product Code: MRR-A339DAEFAC71

[193 Pages Report] The Clinical Laboratory Tests Market size was estimated at USD 135.72 billion in 2023 and expected to reach USD 145.31 billion in 2024, at a CAGR 7.27% to reach USD 221.86 billion by 2030.

The clinical laboratory tests market encompasses the sale and provision of various tests and services by diagnostic laboratories to detect diseases, conditions, or infections. These services include biochemical, genetic, microbiological, pathological, and molecular tests on blood, urine, and tissue specimens. The market serves a wide range of end-users, including hospitals, clinics, standalone laboratories, academic institutions, and others that emphasize preventive care and personalized medicine. Applications of clinical laboratory tests are broad, ranging from routine screening and diagnosis to advanced prognostic and therapeutic monitoring. End-users typically involve healthcare providers, such as hospitals and clinics, that require these tests for patient care, along with pharmaceutical and biotechnology companies leveraging them in drug development processes. In addition, forensic and research institutes utilize these tests for scientific analysis and research purposes. The clinical laboratory tests market is influenced by several growth factors, including an aging population, increasing prevalence of chronic diseases, growing healthcare expenditure globally, and rising preference for personalized medicine. However, the market faces challenges such as high costs associated with clinical laboratory tests and stringent regulatory frameworks for clinical laboratory tests. On the other hand, The market presents potential opportunities through the integration of artificial intelligence and machine learning to increase diagnostic accuracy, the adoption of non-invasive testing methods, and the development of point-of-care diagnostics. Expansion into emerging markets, with a growing healthcare infrastructure, and strategic collaborations for research and development are promising areas for potential growth.

KEY MARKET STATISTICS
Base Year [2023] USD 135.72 billion
Estimated Year [2024] USD 145.31 billion
Forecast Year [2030] USD 221.86 billion
CAGR (%) 7.27%

Test Type: Growing utilization of comprehensive metabolic panel as provides foundational metabolic information with more comprehensive view

The basic metabolic panel calculates the levels of particular substances in the blood, such as glucose, calcium, and electrolytes, providing essential information about the body's metabolism. Calcium is vital in bone health, muscle contraction, nerve function, and blood clotting. The BMP measures total calcium levels in the blood, which is important for detecting bone diseases, parathyroid disorders, and malignancies. Electrolytes such as sodium, potassium, chloride, and bicarbonate are critical for maintaining fluid balance, heart rhythm, muscle function, and other physiological processes. The BMP evaluates the balance of these electrolytes, which can be affected by various factors, including kidney function, fluid intake, medications, and chronic illnesses. The glucose test within the BMP is a fundamental tool for diagnosing diabetes and monitoring glucose control, thereby contributing to effective diabetes management and prevention of complications. Kidney tests within the BMP typically include measurements of blood urea nitrogen (BUN) and creatinine, which indicate kidney function and efficiency in removing waste products from the blood. The complete blood count is a widely performed blood test that evaluates overall health and screens for various disorders, such as anemia and infection. It measures different parts of the blood, such as red blood cells, hemoglobin, white blood cells, hematocrit, and platelets. The comprehensive metabolic panel contains all of the blood tests in the BMP and adds additional markers related to liver function and protein levels. The liver test component of the Comprehensive Metabolic Panel (CMP) includes several critical measurements that assess liver function. Key liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are analyzed to detect any liver injury and hepatocellular diseases. Protein levels in the CMP focus on the two main proteins in the blood: albumin and total protein. Measuring albumin levels can help in establishing the liver's synthetic function, and identifying nutritional deficiencies and kidney diseases. A lipid profile provides a group of tests used to evaluate cardiac risk by measuring the amount of specific lipids in the blood. These typically include cholesterol subtypes LDL (low-density lipoproteins), HDL (high-density lipoprotein), and triglycerides. Thyroid tests often include measurements of thyroid-stimulating hormone (TSH), T3, and T4 to evaluate thyroid function and diagnose thyroid disorders. These tests are pivotal for managing conditions including hypothyroidism and hyperthyroidism. Urinalysis is a test conducted on urine that can detect a wide range of disorders, such as urinary tract infections, kidney disease, and diabetes. It involves several examinations, including the physical, chemical, and microscopic aspects of urine.

Indication: Advancements in the genetic disorder testing with growing significance of predictive analytics and precision medicine

Autoimmune diseases are marked by the immune system mistakenly attacks the body's own cells. Clinical laboratory tests for these diseases are designed to detect autoantibodies and assess organ function. Tests such as Rheumatoid Factor (RF), Antinuclear Antibody (ANA), and Cyclic Citrullinated Peptide (CCP) are widely used. Cardiovascular diseases require tests such as lipid profiles, cardiac biomarkers, coagulation panels, and inflammatory markers. These tests inform on risk assessment, diagnosis, and disease management. For genetic disorders, the focus is on molecular and cytogenetic tests, such as karyotyping, DNA sequencing, and microarray analysis. These tests are used for diagnosing conditions including Down syndrome, cystic fibrosis, and Huntington's disease. Infectious disease laboratory tests are geared toward pathogen identification and include bacterial cultures, PCR testing, serology, and susceptibility testing. These tests are critical for the timely and appropriate treatment of infections. Oncological diagnostics encompass a broad range of tests, including tumor markers, genomic tests, and liquid biopsies. These tests aid in early detection, staging, treatment decisions, and monitoring of cancer patients.

End-User: Increasing preference for independent laboratories due to its broader reach and cost-effectivity

Hospital based laboratories are facilities within a hospital that provide a wide range of clinical tests necessary for diagnosing and treating patients. The need for hospital based laboratories stems from their convenience for inpatient care and their ability to provide rapid results for urgent decision making in patient management. Hospital laboratories are critical for routine blood work, specialized tests for critical care, and emergency diagnostics. Independent laboratories are stand-alone facilities that offer clinical laboratory testing services without being attached to a hospital. They serve both outpatient facilities and individuals, often providing specialized and high-volume testing that might not be cost-effective for smaller hospital labs to perform. The preference for independent laboratories often comes from lower costs, a more comprehensive test menu, and diagnostic services for rare or complex conditions.

Regional Insights

In the United States, the clinical laboratory tests market is driven by advanced healthcare infrastructure, high healthcare spending, and a strong emphasis on research and development. Consumer needs are focused on personalization and convenience, with home test kits gaining popularity. Canadian consumers are increasingly interested in preventative healthcare measures, thus demanding more comprehensive health screening tests. The Canadian government routinely invests in healthcare initiatives, including lab testing, to improve patient outcomes. The European Union's clinical laboratory tests market is regulated by stringent policies and directives that ensure high-quality standards. With an aging population, there's an increased demand for laboratory testing to monitor chronic conditions. Cutting-edge research and notable patents in the EU often relate to improvements in test efficiency and reducing the environmental impact of lab processes. The Middle East and Africa region has seen a surge in health awareness among its population. This rise in health consciousness has translated into an increased demand for preventive healthcare services, which include regular clinical laboratory tests. The growing public interest in early diagnosis and monitoring of health conditions is a significant factor driving the performance of the clinical laboratory tests market in the region. In APAC, China has rapidly expanded its healthcare infrastructure, and the government's increased investment in healthcare reform has led to a heightened demand for clinical laboratory services. India's clinical laboratory tests market is burgeoning with rising healthcare awareness and an increasing prevalence of non-communicable diseases. Privatization and the expansion of health insurance have made laboratory tests more accessible.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Laboratory Tests Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Laboratory Tests Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Laboratory Tests Market, highlighting leading vendors and their innovative profiles. These include Arup Laboratories Inc., Bioscientia Institut fur Medizinische Diagnostik GmbH, Biosino Bio-technology and Science Inc., Charles River Laboratories, Inc, Cinven Ltd., Clinical Reference Laboratory, Inc., DaVita Inc., Eurofins Scientific, Fresenius Medical Care Holdings, Inc., Laboratory Corporation of America Holdings, LifeLabs, Merck KgaA, Novartis International AG, PerkinElmer, Inc., Qiagen .N.V., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Laboratory Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test Type
    • Basic Metabolic Panel
      • Calcium
      • Electrolytes
      • Glucose
      • Kidney Tests
    • Complete Blood Count
    • Comprehensive Metabolic Panel
      • Liver Tests
      • Proteins
    • Lipid Profile
    • Thyroid Test
    • Urinalysis
  • Indication
    • Autoimmune Diseases
    • Cardiovascular Diseases
    • Genetic Disorders
    • Infectious Diseases
    • Oncological Diseases
  • End-User
    • Hospital-Based Laboratories
    • Independent Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Laboratory Tests Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Laboratory Tests Market?

3. What are the technology trends and regulatory frameworks in the Clinical Laboratory Tests Market?

4. What is the market share of the leading vendors in the Clinical Laboratory Tests Market?

5. Which modes and strategic moves are suitable for entering the Clinical Laboratory Tests Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases
      • 5.1.1.2. Growing healthcare expenditure globally
      • 5.1.1.3. Rising preference for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with clinical laboratory tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing need for point-of-care testing
      • 5.1.3.2. Integration of digital solutions with clinical laboratory testing
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory frameworks for clinical laboratory test
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Test Type: Growing utilization of comprehensive metabolic panel as provides foundational metabolic information with more comprehensive view
    • 5.2.2. Indication: Advancements in the genetic disorder testing with growing significance of predictive analytics and precision medicine
    • 5.2.3. End-User: Increasing preference for independent laboratories due to its broader reach and cost-effectivity
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Clinical Laboratory Tests Market, by Test Type

  • 6.1. Introduction
  • 6.2. Basic Metabolic Panel
  • 6.3. Complete Blood Count
  • 6.4. Comprehensive Metabolic Panel
  • 6.5. Lipid Profile
  • 6.6. Thyroid Test
  • 6.7. Urinalysis

7. Clinical Laboratory Tests Market, by Indication

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cardiovascular Diseases
  • 7.4. Genetic Disorders
  • 7.5. Infectious Diseases
  • 7.6. Oncological Diseases

8. Clinical Laboratory Tests Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospital-Based Laboratories
  • 8.3. Independent Laboratories

9. Americas Clinical Laboratory Tests Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Laboratory Tests Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Laboratory Tests Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Oncquest Laboratories Ltd. partners with Shruti Clinical Laboratory to strengthen its presence in the commercial capital Mumbai
    • 12.3.2. Redcliffe Labs acquires Medicentre Sonography & Clinical Lab
    • 12.3.3. Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio